Spectrum of Study Experiences

• Behavioural and autonomic toxicity studies
• Bioequivalence/Bioavailability
• Biomarkers
• Bridging studies
• Interaction studies
  • Drug-Drug
  • Drug-Food
• Children's medicines
• First-in-man
• In-vivo/In-vitro
• Intensive care studies
• Long-term studies
• Micro-dosing (Exploratory IND / Phase 0 Clinical Trials)
• Narcotics
• Nutritional supplements 
• PET studies for PK, PD
• Pharmocokinetic studies
• Pharmacodynamic studies
• Radiopharmaceutical studies
• Thorough QT/QTc studies
• Vaccine studies

Special Assessment Methods 

• Cognitive functions (Vienna Testsystem™)
• Functional MRI (fMRI)
• Gastroscopy
• Heart rate variability (chart™)
• Magnetic capsule (»click here for more information«)
• Magnetic marker monitoring
• Molecular Imaging with PET and SPECT
• Positron emission tomography (PET)
• Pharmaco-EEG (Schwarzer™, Cateem™)
• Single Photon Emission Computed Tomography (SPECT)
• Sensor method (Resorption)
• Skin conductance responses (PowerLab™)

Unit Characteristics

• Intensive care units: 3 with up to 12 beds
• Long-term hospitalisation: up to 14 days
• Maximum number of beds/unit: 80

Special populations 

Volunteers

• Postmenopausal
• Elderly persons

Patients

• Hepatic & renal impairment
• Inflammatory gastric disease
• Chronical pain status
• Chronic Obstructive Pulmonary diseases (COPD)

 

 

 

»back to overview«